BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 23477758)

  • 1. [Clinical guidelines for diagnosis and treatment of prolactinoma and hyperprolactinemia].
    Halperin Rabinovich I; Cámara Gómez R; García Mouriz M; Ollero García-Agulló D;
    Endocrinol Nutr; 2013; 60(6):308-19. PubMed ID: 23477758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical practice guideline for the diagnosis and treatment of hyperprolactinemia].
    Salazar-López-Ortiz CG; Hernández-Bueno JA; González-Bárcena D; López-Gamboa M; Ortiz-Plata A; Porias-Cuéllar HL; Rembao-Bojórquez JD; Sandoval-Huerta GA; Tapia-Serrano R; Vázquez-Castillo GG; Vital-Reyes VS
    Ginecol Obstet Mex; 2014 Feb; 82(2):123-42. PubMed ID: 24779268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas.
    Casanueva FF; Molitch ME; Schlechte JA; Abs R; Bonert V; Bronstein MD; Brue T; Cappabianca P; Colao A; Fahlbusch R; Fideleff H; Hadani M; Kelly P; Kleinberg D; Laws E; Marek J; Scanlon M; Sobrinho LG; Wass JA; Giustina A
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):265-73. PubMed ID: 16886971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hyperprolactinemia unrelated to prolactinoma].
    Krysiak R; Okopień B
    Wiad Lek; 2014; 67(2 Pt 1):101-11. PubMed ID: 25764785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controversial issues in the management of hyperprolactinemia and prolactinomas - An overview by the Neuroendocrinology Department of the Brazilian Society of Endocrinology and Metabolism.
    Vilar L; Abucham J; Albuquerque JL; Araujo LA; Azevedo MF; Boguszewski CL; Casulari LA; Cunha Neto MBC; Czepielewski MA; Duarte FHG; Faria MDS; Gadelha MR; Garmes HM; Glezer A; Gurgel MH; Jallad RS; Martins M; Miranda PAC; Montenegro RM; Musolino NRC; Naves LA; Ribeiro-Oliveira Júnior A; Silva CMS; Viecceli C; Bronstein MD
    Arch Endocrinol Metab; 2018; 62(2):236-263. PubMed ID: 29768629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolactinomas.
    Glezer A; Bronstein MD
    Endocrinol Metab Clin North Am; 2015 Mar; 44(1):71-8. PubMed ID: 25732643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Some issues in the diagnosis and treatment of hyperprolactinemia].
    Jin ZM
    Zhonghua Fu Chan Ke Za Zhi; 2008 Apr; 43(4):241-3. PubMed ID: 18843959
    [No Abstract]   [Full Text] [Related]  

  • 8. Hyperprolactinemia and prolactinomas.
    Mancini T; Casanueva FF; Giustina A
    Endocrinol Metab Clin North Am; 2008 Mar; 37(1):67-99, viii. PubMed ID: 18226731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperprolactinemia and prolactinoma.
    Romijn JA
    Handb Clin Neurol; 2014; 124():185-95. PubMed ID: 25248588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preface.
    Grineva E
    Neuroendocrinology; 2019; 109(1):5-6. PubMed ID: 31167201
    [No Abstract]   [Full Text] [Related]  

  • 11. Prolactinoma and hyperprolactinaemia: a transcultural comparative study between Germany as a western, liberal, industrialised country and Syria as an oriental society with a strong Islamic tradition.
    Kann PH; Juratli N; Kabalan Y
    Gynecol Endocrinol; 2010 Oct; 26(10):749-54. PubMed ID: 20500104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperprolactinemia in children: clinical features and long-term results.
    Catli G; Abaci A; Altincik A; Demir K; Can S; Buyukgebiz A; Bober E
    J Pediatr Endocrinol Metab; 2012; 25(11-12):1123-8. PubMed ID: 23329759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Italian Association of Clinical Endocrinologists (AME) and International Chapter of Clinical Endocrinology (ICCE). Position statement for clinical practice: prolactin-secreting tumors.
    Cozzi R; Ambrosio MR; Attanasio R; Battista C; Bozzao A; Caputo M; Ciccarelli E; De Marinis L; De Menis E; Faustini Fustini M; Grimaldi F; Lania A; Lasio G; Logoluso F; Losa M; Maffei P; Milani D; Poggi M; Zini M; Katznelson L; Luger A; Poiana C
    Eur J Endocrinol; 2022 Feb; 186(3):P1-P33. PubMed ID: 35000899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prolactinoma].
    Krysiak R; Okopień B; Marek B; Szkróbka W
    Przegl Lek; 2009; 66(4):198-205. PubMed ID: 19708510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hyperprolactinemia and prolactinomas].
    Croughs RJ; van 't Verlaat JW
    Ned Tijdschr Geneeskd; 1991 Nov; 135(47):2210-3. PubMed ID: 1956454
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hyperprolactinemia. II. Diagnosis and treatment].
    Widala E; Nowakowski G; Kochańska-Dziurowicz AA
    Przegl Lek; 1999; 56(12):807-11. PubMed ID: 10789194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and treatment of prolactinomas.
    Molitch ME
    Adv Intern Med; 1999; 44():117-53. PubMed ID: 9929707
    [No Abstract]   [Full Text] [Related]  

  • 18. The epidemiology, diagnosis and treatment of Prolactinomas: The old and the new.
    Chanson P; Maiter D
    Best Pract Res Clin Endocrinol Metab; 2019 Apr; 33(2):101290. PubMed ID: 31326373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prolactinoma].
    Glezer A; Bronstein MD
    Arq Bras Endocrinol Metabol; 2014 Mar; 58(2):118-23. PubMed ID: 24830588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acromegaly with moderate hyperprolactinemia caused by an intrasellar macroadenoma.
    Bonert VS; Melmed S
    Nat Clin Pract Endocrinol Metab; 2006 Jul; 2(7):408-12; quiz following 412. PubMed ID: 16932323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.